Medical management of a large aortic thrombus in a young woman with essential thrombocythemia

Mayo Clinic Proceedings

Volumn 76, Issue 4, 2001, Pages 427-431

  Fang, Ming ^a,b   Agha, Samina ^a   Lockridge, Leslie ^a   Lee, Ronald ^a   Cleary, Joseph P ^a   Mazur, Eric M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; FIBRIN; HYDROXYUREA;

ADULT; AORTA THROMBOSIS; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; EMBOLISM; FEMALE; FIBRIN CLOT; HUMAN; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTHEMIA; THROMBOCYTOSIS; TREATMENT OUTCOME;

EID: 0035088233     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/76.4.427     Document Type: Article

References (38)

1. Provenzale D, Schmitt C, Wong JB, Barren's esophagus: a new look at surveillance based on emerging estimates of cancer risk. Am J Gastroenterol. 1999;94:2043-2053.
2. Fera M, Trastek VF, Carpenter HA, Alien MS, Deschamps C, Pairolero PC, Barren's esophagus with high-grade dysplasia: an indication for esophagectomy? Ann Thorac Surg. 1992;54:199-204.
3. Nigro JJ, Hagen JA, DeMeester TR, et al, Occult esophageal adenocarcinoma: extent of disease and implications for effective therapy. Ann Surg. 1999;230:433-438.
4. Van der Veen AH, Dees J, Blankensteijn JD, Van Blankenstein M, Adenocarcinoma in Barren's oesophagus: an overrated risk. Gut. 1989;30:14-18.
5. Bonavina L, Group Européen pour l'Etude des Maladies de l'Oesophage, Early oesophageal cancer: results of a European multicentre survey. Br J Surg. 1995;82:98-101.
6. Patti MG, Corvera CU, Glasgow RE, Way LW, A hospital's annual rate of esophagectomy influences the operative mortality rate. / Gastrointest Surg. 1998;2:186-192.
7. Swisher SG, Deford L, Merriman KW, et al, Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer. J Thorac Cardiovasc Surg. 2000; 119:1126-1132.
8. Sampliner RE, Effect of up to 3 years of high-dose lansoprazole on Barren's esophagus. Am J Gastroenterol. 1994;89:1844-1848.
9. Sharma P, Sampliner RE, Camargo E, Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barren's esophagus. Am J Gastroenterol. 1997;92: 582-585.
10. Sampliner RE, Ablative therapies for the columnar-lined esophagus. Gastroenterol Clin North Am. 1997;26:685-694.
11. Dougherty TJ, Corner CJ, Henderson BW, et al, Photodynamic therapy. J Natl Cancer Inst. 1998:90:889-905.
12. Wang KK, Current status of photodynamic therapy of Barren's esophagus. Gastointest Endosc. 1999;49(3, pt 2):S20-S23.
13. Gossner L, May A, Sroka R, Stolte M, Hahn EG, Ell C, Photodynamic destruction of high grade dysplasia and early carcinoma of the esophagus after the oral administration of 5-aminolevulinic acid. Cancer. 1999;86:1921-1928.
14. Gossner L, May A, Sroka R, Ell C, A new long-range through-thescope balloon applicator for photodynamic therapy in the esophagus and cardia. Endoscopy. 1999;31:370-376.
15. Overholt BF, Panjehpour M, Haydek JM, Photodynamic therapy for Barren's esophagus: follow-up in 100 patients. Gastrointest Endosc. 1999;49:l-7.
16. Barr H, Shepherd NA, Dix A, Roberts DJ, Tan WC, Krasner N, Eradication of high-grade dysplasia in columnar-lined (Barren's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX. Lancet. 1996;348:584-585.
17. Loh CS, Vernon D, MacRobert AJ, Bedwell J, Bown SG, Brown SB, Endogenous porphyrin distribution induced by 5-aminolaevulinic acid in the tissue layers of the gastrointestinal tract. J Photochem Photobiol B. 1993;20:47-54.
18. Gossner L, Stolte M, Sroka R, et al, Photodynamic ablation of highgrade dysplasia and early cancer in Barren's esophagus by means of 5-aminolevulinic acid. Gastroenterology. 1998;1 14:448-455.
19. Baas P, Oppelaar H, van der Valk MA, van Zandwijk N, Stewart FA, Partial protection of photodynamic-induced skin reactions in mice by N-acetylcysteine: a preclinical study. Photochem Photobiol. 1994;59:448-454.
20. Sampliner RE, Fennerty B, Garewal HS, Reversal of Barren's esophagus with acid suppression and multipolar electrocoagulation: preliminary results. Gastrointest En dose. 1996;44:532-535.
21. Van Laethem JL, Cremer M, Peny MO, Delhaye M, Deviere J, Eradication of Barren's mucosa with argon plasma coagulation and acid suppression: immediate and mid term results. Gut. 1998;43: 747-751.
22. Dumoulin FL, Terjung B, Neubrand M, Scheurlen C, Fischer HP, Sauerbruch T, Treatment of Barren's esophagus by endoscopie argon plasma coagulation. Endoscopy. 1997:29:751-753.
23. Gossner L, May A, Stolte M, Seitz G, Hahn EG, Ell C, KTP laser destruction of dysplasia and early cancer in columnar-lined Barren's esophagus. Gastrointest Endosc. 1999;49:8-12.
24. Sharma P, Jaffe PE, Bhattacharyya A, Sampliner RE, Laser and multipolar electrocoagulation ablation of early Barren's adenocarcinoma: long-term follow-up. Gastrointest Endosc. 1999;49(4, pt l):442-446.
25. Alexander GL, Wang KK, Ahlquist DA, Viggiano TR, Gostout CJ, Balm R, Does performance status influence the outcome of Nd:YAG laser therapy of proximal esophageal tumors? Gastrointest Endosc. 1994;40:451-454.
26. Berenson MM, Johnson TD, Markowitz NR, Buchi KN, Samowitz WS, Restoration of squamous mucosa after ablation of Barren's esophageal epithelium. Gastroenterology. 1993;104:1686-1691.
27. Sampliner RE, Hixson LJ, Fennerty MB, Garewal HS, Regression of Barren's esophagus by laser ablation in an anacid environment. Dig Dis Sei. 1993;38:365-368.
28. Sharma P, Bhattacharyya A, Garewal HS, Sampliner RE, Durability of new squamous epithelium after endoscopie reversal of Barren's esophagus. Gastrointest Endosc. 1999;50:159-164.
29. Garewal H, Ramsey L, Sharma P, Kraus K, Sampliner R, Pass R, Biomarker studies in reversed Barrett's esophagus. Am J Gastroenterol. 1999;94:2829-2833.
30. Kovacs BJ, Chen YK, Lewis TD, DeGuzman LJ, Thompson KS, Successful reversal of Barren's esophagus with multipolar electrocoagulation despite inadequate acid suppression. Gastrointest Endosc. 1999:49:547-553.
31. Michopoulos S, Tsibouris P, Bouzakis H, Sotiropoulou M, Kralios N, Complete regression of Barrett's esophagus with heat probe thermocoagulation: mid-term results. Gastrointest Endosc. 1999; 50:165-172.
32. Grade AJ, Shah IA, Medlin SM, Ramirez FC, The efficacy and safety of argon plasma coagulation therapy in Barrett's esophagus. Gastrointest Endosc. 1999;50:18-22.
33. Mork H, Barth T, Kreipe HH, et al, Reconstitution of squamous epithelium in Barrett's oesophagus with endoscopie argon plasma coagulation: a prospective study. Scand J Gastroenterol. 1998;33: 1130-1134.
34. Byrne JP, Armstrong GR, Attwood SE, Restoration of the normal squamous lining in Barrett's esophagus by argon beam plasma coagulation. Am J Gastroenterol. 1998:93:1810-1815.
35. Nijahwan PK, Wang KK, Endoscopie mucosal resection for lesions with endoscopie features suggestive of malignancy and high-grade dysplasia within Barrett's esophagus. Gastrointest Endosc. 2000;52: 328-332.
36. Inoue H, Tani M, Nagai K, et al, Treatment of esophageal and gastric tumors. Endoscopy. 1999;31:47-55.
37. Ell C, May A, Gossner L, et al, Endoscopie mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology. 2000;1 18:670-677.
38. Brandt LJ, Blansky RL, Kauvar DR, Repeat laser therapy of recurrent Barrett's epithelium: success with anacidity [letter]. Gastrointest Endosc. 1995;41:267.